Cortactin: A multifunctional regulator of cellular invasiveness

Cell Adhesion and Migration

Volumn 5, Issue 2, 2011, Pages 187-198

  Kirkbride, Kellye C ^a   Sung, Bong Hwan ^a   Sinha, Seema ^a   Weaver, Alissa M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Actin; Actin assembly; Cancer; Cortactin; Invadopodia; Invasion; Lamellipodia; Membrane trafficking; Migration; Scaffold; Secretion

Indexed keywords

ABELSON KINASE; ACTIN; ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 3; CALDESMON; CD2 ASSOCIATED PROTEIN; CORTACTIN; DYNAMIN II; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HISTONE DEACETYLASE 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; NON MUSLCE MYOSIN LIGHT CHAIN KINASE; P21 ACTIVATED KINASE 1; POTASSIUM CHANNEL KV1.2; PROTEIN ASAP1; PROTEIN BPGAP1; PROTEIN CORTBP1; PROTEIN FGD1; PROTEIN HIP1R; PROTEIN KINASE SYK; PROTEIN MIM; PROTEIN NCK1; PROTEIN P120; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN ZO1; SCATTER FACTOR RECEPTOR; SIRTUIN 1; UNCLASSIFIED DRUG;

AUTOCRINE EFFECT; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CELL MOTION; HUMAN; NONHUMAN; REVIEW;

EID: 79952328998     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.5.2.14773     Document Type: Review

References (210)

1. Jay PY, Pham PA, Wong SA, Elson EL. A mechanical function of myosin II in cell motility. J Cell Sci 1995; 108:387-93.
2. Vicente-Manzanares M, Zareno J, Whitmore L, Choi CK, Horwitz AF. Regulation of protrusion, adhesion dynamics and polarity by myosins IIA and IIB in migrating cells. J Cell Biol 2007; 176:573-80. (Pubitemid 46333973)
3. Mullins RD, Heuser JA, Pollard TD. The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping and formation of branching networks of filaments. Proc Natl Acad Sci USA 1998; 95:6181-6. (Pubitemid 28248985)
4. Svitkina TM, Borisy GG. Arp2/3 complex and actin depolymerizing factor/cofilin in dendritic organization and treadmilling of actin filament array in lamellipodia. J Cell Biol 1999; 145:1009-26. (Pubitemid 29270059)
5. Welch MD, DePace AH, Verma S, Iwamatsu A, Mitchison TJ. The human Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin filament assembly. J Cell Biol 1997; 138:375-84. (Pubitemid 27323539)
6. Machesky LM, Atkinson SJ, Ampe C, Vandekerckhove J, Pollard TD. Purification of a cortical complex containing two unconventional actins from Acanthamoeba by affinity chromatography on profilin-agarose. J Cell Biol 1994; 127:107-15. (Pubitemid 24307660)
7. Machesky LM, Mullins RD, Higgs HN, Kaiser DA, Blanchoin L, May RC, et al. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex. Proc Natl Acad Sci USA 1999; 96:3739-44. (Pubitemid 29168980)
8. Oikawa T, Yamaguchi H, Itoh T, Kato M, Ijuin T, Yamazaki D, et al. PtdIns(3,4,5)P3 binding is necessary for WAVE2-induced formation of lamellipodia. Nat Cell Biol 2004; 6:420-6.
9. Suetsugu S, Miki H, Yamaguchi H, Takenawa T. Requirement of the basic region of N-WASP/WAVE2 for actin-based motility. Biochem Biophys Res Commun 2001; 282:739-44. (Pubitemid 32924620)
10. Suetsugu S, Yamazaki D, Kurisu S, Takenawa T. Differential roles of WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell migration. Dev Cell 2003; 5:595-609. (Pubitemid 37243048)
11. Weed SA, Karginov AV, Schafer DA, Weaver AM, Kinley AW, Cooper JA, et al. Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol 2000; 151:29-40.
12. Uruno T, Liu J, Zhang P, Fan Yx Y, Egile C, Li R, et al. Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol 2001; 3:259-66. (Pubitemid 32201321)
13. Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT, et al. Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol 2001; 11:370-4. (Pubitemid 32200742)
14. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999; 18:4440-9. (Pubitemid 29396652)
15. Wu H, Parsons JT. Cortactin, an 80/85 kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 1993; 120:1417-26. (Pubitemid 23081688)
16. Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT. Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 1991; 11:5113-24. (Pubitemid 21895272)
17. Schuuring E, Verhoeven E, Litvinov S, Michalides RJ. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol 1993; 13:2891-8. (Pubitemid 23133960)
18. van Rossum AG, Schuuring-Scholtes E, van Buurenvan Seggelen V, Kluin PM, Schuuring E. Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain. BMC Genom 2005; 6:15.
19. Hiura K, Lim SS, Little SP, Lin S, Sato M. Differentiation dependent expression of tensin and cortactin in chicken osteoclasts. Cell Motil Cytoskeleton 1995; 30:272-84.
20. Hill A, McFarlane S, Mulligan K, Gillespie H, Draffin JE, Trimble A, et al. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene 2006; 25:6079-91. (Pubitemid 44562406)
21. Du XL, Yang H, Liu SG, Luo ML, Hao JJ, Zhang Y, et al. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene 2009; 28:3714-22.
22. Gibcus JH, Mastik MF, Menkema L, de Bock GH, Kluin PM, Schuuring E, et al. Cortactin expression predicts poor survival in laryngeal carcinoma. Br J Cancer 2008; 98:950-5. (Pubitemid 351341606)
23. Greer RO Jr, Said S, Shroyer KR, Marileila VG, Weed SA. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Oral Oncol 2007; 43:735-41. (Pubitemid 47259438)
24. Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suarez C. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 2000; 6:3177-82. (Pubitemid 30637745)
25. Yuan BZ, Zhou X, Zimonjic DB, Durkin ME, Popescu NC. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma. J Mol Diagn 2003; 5:48-53. (Pubitemid 36193000)
26. Weaver AM, Heuser JE, Karginov AV, Lee WL, Parsons JT, Cooper JA. Interaction of cortactin and N-WASp with Arp2/3 complex. Curr Biol 2002; 12:1270-8. (Pubitemid 34869876)
27. Pant K, Chereau D, Hatch V, Dominguez R, Lehman W. Cortactin binding to F-actin revealed by electron microscopy and 3D reconstruction. J Mol Biol 2006; 359:840-7. (Pubitemid 43831917)
28. Shvetsov A, Berkane E, Chereau D, Dominguez R, Reisler E. The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actin. Cell Motil Cytoskeleton 2009; 66:90-8.
29. Weed SA, Parsons JT. Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 2001; 20:6418-34. (Pubitemid 32977848)
30. Goode BL, Rodal AA, Barnes G, Drubin DG. Activation of the Arp2/3 complex by the actin filament binding protein Abp1p. J Cell Biol 2001; 153:627-34. (Pubitemid 34280148)
31. Olazabal IM, Machesky LM. Abp1p and cortactin, new "hand-holds" for actin. J Cell Biol 2001; 154:679-82.
32. Katsube T, Takahisa M, Ueda R, Hashimoto N, Kobayashi M, Togashi S. Cortactin associates with the cell-cell junction protein ZO-1 in both Drosophila and mouse. J Biol Chem 1998; 273:29672-7. (Pubitemid 28509977)
33. Ohoka Y, Takai Y. Isolation and characterization of cortactin isoforms and a novel cortactin-binding protein, CBP90. Genes Cells 1998; 3:603-12. (Pubitemid 28518309)
34. van Rossum AG, de Graaf JH, Schuuring-Scholtes E, Kluin PM, Fan YX, Zhan X, et al. Alternative splicing of the actin binding domain of human cortactin affects cell migration. J Biol Chem 2003; 278:45672-9. (Pubitemid 37432709)
35. Katsube T, Togashi S, Hashimoto N, Ogiu T, Tsuji H. Filamentous actin binding ability of cortactin isoforms is responsible for their cell-cell junctional localization in epithelial cells. Arch Biochem Biophys 2004; 427:79-90. (Pubitemid 38725916)
36. Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell 2007; 27:197-213. (Pubitemid 47058299)
37. Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, et al. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 2009; 28:445-60.
38. Rey M, Irondelle M, Waharte F, Lizarraga F, Chavrier P. HDAC6 is required for invadopodia activity and invasion by breast tumor cells. Eur J Cell Biol 2010; In press.
39. Ammer AG, Weed SA. Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil Cytoskeleton 2008; 65:687-707.
40. Lua BL, Low BC. Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett 2005; 579:577-85.
41. Zhan X, Hu X, Hampton B, Burgess WH, Friesel R, Maciag T. Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G1 phase of the BALB/c 3T3 cell cycle. J Biol Chem 1993; 268:24427-31. (Pubitemid 23335437)
42. Zhan X, Plourde C, Hu X, Friesel R, Maciag T. Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin. J Biol Chem 1994; 269:20221-4. (Pubitemid 24260413)
43. Kelley LC, Hayes KE, Ammer AG, Martin KH, Weed SA. Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence. PLoS One 2010; 5:13847.
44. Oser M, Mader CC, Gil-Henn H, Magalhaes M, Bravo-Cordero JJ, Koleske AJ, et al. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J Cell Sci 2010; 123:3662-73.
45. Boyle SN, Michaud GA, Schweitzer B, Predki PF, Koleske AJ. A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol 2007; 17:445-51.
46. Ozawa K, Kashiwada K, Takahashi M, Sobue K. Translocation of cortactin (p80/85) to the actin-based cytoskeleton during thrombin receptor-mediated platelet activation. Exp Cell Res 1995; 221:197-204.
47. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004; 279:24692-700. (Pubitemid 38725337)
48. Ren G, Helwani FM, Verma S, McLachlan RW, Weed SA, Yap AS. Cortactin is a functional target of E-cadherin-activated Src family kinases in MCF7 epithelial monolayers. J Biol Chem 2009; 284:18913-22.
49. Dehio C, Prevost MC, Sansonetti PJ. Invasion of epithelial cells by Shigella flexneri induces tyrosine phosphorylation of cortactin by a pp60c-src-mediated signalling pathway. EMBO J 1995; 14:2471-82.
50. Vuori K, Ruoslahti E. Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J Biol Chem 1995; 270:22259-62.
51. Eiseler T, Hausser A, De Kimpe L, Van Lint J, Pfizenmaier K. Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J Biol Chem 2010; 285:18672-83.
52. Crostella L, Lidder S, Williams R, Skouteris GG. Hepatocyte Growth Factor/scatter factor-induces phosphorylation of cortactin in A431 cells in a Src kinasein-dependent manner. Oncogene 2001; 20:3735-45. (Pubitemid 32624965)
53. Gallet C, Rosa JP, Habib A, Lebret M, Levy-Toledano S, Maclouf J. Tyrosine phosphorylation of cortactin associated with Syk accompanies thromboxane analogue-induced platelet shape change. J Biol Chem 1999; 274:23610-6.
54. Grassart A, Meas-Yedid V, Dufour A, Olivo-Marin JC, Dautry-Varsat A, Sauvonnet N. Pak1 phosphorylation enhances Cortactin-N-WASP interaction in clathrin-caveolin-independent endocytosis. Traffic 2010; 11:1079-91.
55. Kapus A, Di Ciano C, Sun J, Zhan X, Kim L, Wong TW, et al. Cell volume-dependent phosphorylation of proteins of the cortical cytoskeleton and cell-cell contact sites. The role of Fyn and FER kinases. J Biol Chem 2000; 275:32289-98.
56. Kim L, Wong TW. Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER. J Biol Chem 1998; 273:23542-8. (Pubitemid 28417547)
57. Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N, Geha RS. Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol 2004; 24:5269-80. (Pubitemid 38738162)
58. Maruyama S, Kurosaki T, Sada K, Yamanashi Y, Yamamoto T, Yamamura H. Physical and functional association of cortactin with Syk in human leukemic cell line K562. J Biol Chem 1996; 271:6631-5. (Pubitemid 26104090)
59. Webb BA, Zhou S, Eves R, Shen L, Jia L, Mak AS. Phosphorylation of cortactin by p21-activated kinase. Arch Biochem Biophys 2006; 456:183-93. (Pubitemid 44880282)
60. Lapetina S, Mader CC, Machida K, Mayer BJ, Koleske AJ. Arg interacts with cortactin to promote adhesion-dependent cell edge protrusion. J Cell Biol 2009; 185:503-19.
61. Oser M, Yamaguchi H, Mader CC, Bravo-Cordero JJ, Arias M, Chen X, et al. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J Cell Biol 2009; 186:571-87.
62. Okamura H, Resh MD. p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells. J Biol Chem 1995; 270:26613-8. (Pubitemid 3006243)
63. Tehrani S, Tomasevic N, Weed S, Sakowicz R, Cooper JA. Src phosphorylation of cortactin enhances actin assembly. Proc Natl Acad Sci USA 2007; 104:11933-8. (Pubitemid 47185608)
64. Zhu J, Yu D, Zeng XC, Zhou K, Zhan X. Receptor-mediated endocytosis involves tyrosine phosphorylation of cortactin. J Biol Chem 2007; 282:16086-94. (Pubitemid 47100381)
65. Martin KH, Jeffery ED, Grigera PR, Shabanowitz J, Hunt DF, Parsons JT. Cortactin phosphorylation sites mapped by mass spectrometry. J Cell Sci 2006; 119:2851-3. (Pubitemid 44177862)
66. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ, Weaver AM. Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol 2005; 15:1276-85. (Pubitemid 41026593)
67. Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tete S, Luini A, et al. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci 2008; 121:369-78. (Pubitemid 351356708)
68. Kinley AW, Weed SA, Weaver AM, Karginov AV, Bissonette E, Cooper JA, et al. Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion. Curr Biol 2003; 13:384-93. (Pubitemid 36280455)
69. Lai FP, Szczodrak M, Oelkers JM, Ladwein M, Acconcia F, Benesch S, et al. Cortactin promotes migration and platelet-derived growth factor-induced actin reorganization by signaling to Rho-GTPases. Mol Biol Cell 2009; 20:3209-23.
70. Head JA, Jiang D, Li M, Zorn LJ, Schaefer EM, Parsons JT, et al. Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoskeleton. Mol Biol Cell 2003; 14:3216-29. (Pubitemid 37013122)
71. Huang C, Liu J, Haudenschild CC, Zhan X. The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem 1998; 273:25770-6. (Pubitemid 28475803)
72. Kowalski JR, Egile C, Gil S, Snapper SB, Li R, Thomas SM. Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 2005; 118:79-87. (Pubitemid 40277106)
73. Patel AS, Schechter GL, Wasilenko WJ, Somers KD. Overexpression of EMS1/cortactin in NIH3T3 fibro-blasts causes increased cell motility and invasion in vitro. Oncogene 1998; 16:3227-32. (Pubitemid 28330420)
74. Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA, et al. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 2006; 66:8017-25. (Pubitemid 44299166)
75. van Rossum AG, Moolenaar WH, Schuuring E. Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp Cell Res 2006; 312:1658-70.
76. Tanaka S, Kunii M, Harada A, Okabe S. Generation of cortactin floxed mice and cellular analysis of motility in fibroblasts. Genesis 2009; 47:638-46.
77. Somogyi K, Rorth P. Cortactin modulates cell migration and ring canal morphogenesis during Drosophila oogenesis. Mech Dev 2004; 121:57-64. (Pubitemid 38050179)
78. Kempiak SJ, Yamaguchi H, Sarmiento C, Sidani M, Ghosh M, Eddy RJ, et al. A neural Wiskott-Aldrich Syndrome protein-mediated pathway for localized activation of actin polymerization that is regulated by cortactin. J Biol Chem 2005; 280:5836-42. (Pubitemid 40280065)
79. Tehrani S, Faccio R, Chandrasekar I, Ross FP, Cooper JA. Cortactin has an essential and specific role in osteoclast actin assembly. Mol Biol Cell 2006; 17:2882-95. (Pubitemid 43993494)
80. Unsworth KE, Way M, McNiven M, Machesky L, Holden DW. Analysis of the mechanisms of Salmonella-induced actin assembly during invasion of host cells and intracellular replication. Cell Microbiol 2004; 6:1041-55. (Pubitemid 39386682)
81. Boguslavsky S, Grosheva I, Landau E, Shtutman M, Cohen M, Arnold K, et al. p120 catenin regulates lamellipodial dynamics and cell adhesion in cooperation with cortactin. Proc Natl Acad Sci USA 2007; 104:10882-7. (Pubitemid 47175195)
82. Gupton SL, Anderson KL, Kole TP, Fischer RS, Ponti A, Hitchcock-DeGregori SE, et al. Cell migration without a lamellipodium: translation of actin dynamics into cell movement mediated by tropomyosin. J Cell Biol 2005; 168:619-31. (Pubitemid 40271027)
83. DiMilla PA, Barbee K, Lauffenburger DA. Mathematical model for the effects of adhesion and mechanics on cell migration speed. Biophys J 1991; 60:15-37.
84. Gupton SL, Waterman-Storer CM. Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 2006; 125:1361-74. (Pubitemid 43929092)
85. Borm B, Requardt RP, Herzog V, Kirfel G. Membrane ruffles in cell migration: indicators of inefficient lamellipodia adhesion and compartments of actin filament reorganization. Exp Cell Res 2005; 302:83-95. (Pubitemid 39482370)
86. Goldfinger LE, Han J, Kiosses WB, Howe AK, Ginsberg MH. Spatial restriction of alpha4 integrin phosphorylation regulates lamellipodial stability and alpha4beta1-dependent cell migration. J Cell Biol 2003; 162:731-41. (Pubitemid 37022949)
87. Owen KA, Pixley FJ, Thomas KS, Vicente-Manzanares M, Ray BJ, Horwitz AF, et al. Regulation of lamellipodial persistence, adhesion turnover and motility in macrophages by focal adhesion kinase. J Cell Biol 2007; 179:1275-87. (Pubitemid 350277744)
88. Croucher DR, Rickwood D, Tactacan CM, Musgrove EA, Daly RJ. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells. Mol Cell Biol 30:5057-70.
89. Harris KP, Tepass U. Cdc42 and vesicle trafficking in polarized cells. Traffic 2010; 11:1272-9.
90. Clark ES, Weaver AM. A new role for cortactin in invadopodia: Regulation of protease secretion. Eur J Cell Biol 2008; 87:581-90.
91. Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 2007; 67:4227-35. (Pubitemid 46815069)
92. Wu X, Quondamatteo F, Brakebusch C. Cdc42 expression in keratinocytes is required for the maintenance of the basement membrane in skin. Matrix Biol 2006; 25:466-74. (Pubitemid 44751454)
93. Gimona M, Buccione R, Courtneidge SA, Linder S. Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol 2008; 20:235-41.
94. Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 2006; 23:97-105. (Pubitemid 44440169)
95. Oikawa T, Itoh T, Takenawa T. Sequential signals toward podosome formation in NIH-src cells. J Cell Biol 2008; 182:157-69. (Pubitemid 352008629)
96. Oser M, Dovas A, Cox D, Condeelis J. Nck1 and Grb2 localization patterns can distinguish invadopodia from podosomes. Eur J Cell Biol 2010; In press.
97. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, et al. Molecular mechanisms of invadopodium formation: the role of the N-WASPArp2/ 3 complex pathway and cofilin. J Cell Biol 2005; 168:441-52. (Pubitemid 40205066)
98. Artym VV, Matsumoto K, Mueller SC, Yamada KM. Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes. Eur J Cell Biol 2010; In press.
99. Alexander NR, Branch KM, Parekh A, Clark ES, Iwueke IC, Guelcher SA, et al. Extracellular matrix rigidity promotes invadopodia activity. Curr Biol 2008; 18:1295-9.
100. Parekh A, Weaver AM. Regulation of cancer invasiveness by the physical extracellular matrix environment. Cell Adh Migr 2009; 3:288-92.
101. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006; 66:3034-43.
102. Cortesio CL, Chan KT, Perrin BJ, Burton NO, Zhang S, Zhang ZY, et al. Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. J Cell Biol 2008; 180:957-71. (Pubitemid 351398422)
103. Ma T, Sadashivaiah K, Chellaiah MA. Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts. J Biol Chem 285:29911-24.
104. Webb BA, Eves R, Mak AS. Cortactin regulates podosome formation: roles of the protein interaction domains. Exp Cell Res 2006; 312:760-9.
105. Webb BA, Jia L, Eves R, Mak AS. Dissecting the functional domain requirements of cortactin in invadopodia formation. Eur J Cell Biol 2007; 86:189-206. (Pubitemid 46404601)
106. Ayala I, Giacchetti G, Caldieri G, Attanasio F, Mariggio S, Tete S, et al. Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is upregulated in prostate and breast cancer. Cancer Res 2009; 69:747-52.
107. Yamaguchi H, Miki H, Takenawa T. Neural Wiskott-Aldrich syndrome protein is involved in hepatocyte growth factor-induced migration, invasion and tubulogenesis of epithelial cells. Cancer Res 2002; 62:2503-9. (Pubitemid 34462726)
108. Steffen A, Le Dez G, Poincloux R, Recchi C, Nassoy P, Rottner K, et al. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7. Curr Biol 2008; 18:926-31.
109. Clark ES, Brown B, Whigham AS, Kochaishvili A, Yarbrough WG, Weaver AM. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene 2009; 28:431-44.
110. Eitzen G. Actin remodeling to facilitate membrane fusion. Biochim Biophys Acta 2003; 1641:175-81. (Pubitemid 36952597)
111. Lanzetti L. Actin in membrane trafficking. Curr Opin Cell Biol 2007; 19:453-8. (Pubitemid 47268758)
112. Liu J, Yue P, Artym VV, Mueller SC, Guo W. The role of the exocyst in matrix metalloproteinase secretion and actin dynamics during tumor cell invadopodia formation. Mol Biol Cell 2009; 20:3763-71.
113. Cao H, Chen J, Krueger EW, McNiven MA. SRCmediated phosphorylation of dynamin and cortactin regulates the "constitutive" endocytosis of transferrin. Mol Cell Biol 2010; 30:781-92.
114. Cao H, Orth JD, Chen J, Weller SG, Heuser JE, McNiven MA. Cortactin is a component of clathrincoated pits and participates in receptor-mediated endocytosis. Mol Cell Biol 2003; 23:2162-70. (Pubitemid 36278824)
115. Engqvist-Goldstein AE, Zhang CX, Carreno S, Barroso C, Heuser JE, Drubin DG. RNAi-mediated Hip1R silencing results in stable association between the endocytic machinery and the actin assembly machinery. Mol Biol Cell 2004; 15:1666-79. (Pubitemid 38401817)
116. Merrifield CJ, Perrais D, Zenisek D. Coupling between clathrin-coated-pit invagination, cortactin recruitment and membrane scission observed in live cells. Cell 2005; 121:593-606. (Pubitemid 40720012)
117. Sauvonnet N, Dujeancourt A, Dautry-Varsat A. Cortactin and dynamin are required for the clathrinin-dependent endocytosis of {gamma}c cytokine receptor. J Cell Biol 2005; 168:155-63. (Pubitemid 40111065)
118. Zhu J, Zhou K, Hao JJ, Liu J, Smith N, Zhan X. Regulation of cortactin/dynamin interaction by actin polymerization during the fission of clathrin-coated pits. J Cell Sci 2005; 118:807-17. (Pubitemid 40372588)
119. Timpson P, Lynch DK, Schramek D, Walker F, Daly RJ. Cortactin overexpression inhibits ligand-induced downregulation of the epidermal growth factor receptor. Cancer Res 2005; 65:3273-80. (Pubitemid 40524611)
120. Barroso C, Rodenbusch SE, Welch MD, Drubin DG. A role for cortactin in Listeria monocytogenes invasion of NIH 3T3 cells, but not in its intracellular motility. Cell Motil Cytoskeleton 2006; 63:231-43.
121. Cao H, Weller S, Orth JD, Chen J, Huang B, Chen JL, et al. Actin and Arf1-dependent recruitment of a cortactin-dynamin complex to the Golgi regulates post-Golgi transport. Nat Cell Biol 2005; 7:483-92. (Pubitemid 40637408)
122. Sakurai-Yageta M, Recchi C, Le Dez G, Sibarita JB, Daviet L, Camonis J, et al. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J Cell Biol 2008; 181:985-98. (Pubitemid 351846831)
123. Sbai O, Ould-Yahoui A, Ferhat L, Gueye Y, Bernard A, Charrat E, et al. Differential vesicular distribution and trafficking of MMP-2, MMP-9 and their inhibitors in astrocytes. Glia 2009; 58:344-66.
124. Naisbitt S, Kim E, Tu JC, Xiao B, Sala C, Valtschanoff J, et al. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 1999; 23:569-82. (Pubitemid 29359927)
125. Riefler GM, Balasingam G, Lucas KG, Wang S, Hsu SC, Firestein BL. Exocyst complex subunit sec8 binds to postsynaptic density protein-95 (PSD-95): a novel interaction regulated by cypin (cytosolic PSD-95 interactor). Biochem J 2003; 373:49-55.
126. Hsu SC, TerBush D, Abraham M, Guo W. The exocyst complex in polarized exocytosis. Int Rev Cytol 2004; 233:243-65. (Pubitemid 38420353)
127. Zuo X, Zhang J, Zhang Y, Hsu SC, Zhou D, Guo W. Exo70 interacts with the Arp2/3 complex and regulates cell migration. Nat Cell Biol 2006; 8:1383-8. (Pubitemid 44835113)
128. Baldassarre M, Pompeo A, Beznoussenko G, Castaldi C, Cortellino S, McNiven MA, et al. Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell 2003; 14:1074-84. (Pubitemid 36337453)
129. Onodera Y, Hashimoto S, Hashimoto A, Morishige M, Mazaki Y, Yamada A, et al. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J 2005; 24:963-73. (Pubitemid 40470145)
130. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992; 7:355-61.
131. Cai JH, Zhao R, Zhu JW, Jin XL, Wan FJ, Liu K, et al. Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma. J Gastrointest Surg 14:1248-57.
132. Lin CK, Su HY, Tsai WC, Sheu LF, Jin JS. Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters. Dis Markers 2008; 25:17-26.
133. Luo ML, Shen XM, Zhang Y, Wei F, Xu X, Cai Y, et al. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 2006; 66:11690-9. (Pubitemid 46094181)
134. Wang X, Cao W, Mo M, Wang W, Wu H, Wang J. VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer. J Surg Oncol 102:325-30.
135. Xie HL, Li ZY, Gan RL, Li XJ, Zhang QL, Hui M, et al. Differential gene and protein expression in primary gastric carcinomas and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. J Dig Dis 11:167-75.
136. Xu XZ, Garcia MV, Li TY, Khor LY, Gajapathy RS, Spittle C, et al. Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod Pathol 23:187-96.
137. Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, et al. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res 2007; 13:6257-66. (Pubitemid 350075013)
138. Roy PG, Thompson AM. Cyclin D1 and breast cancer. Breast 2006; 15:718-27.
139. Rodrigo JP, Garcia-Carracedo D, Garcia LA, Menendez S, Allonca E, Gonzalez MV, et al. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 2009; 217:516-23.
140. Fantozzi I, Grall D, Cagnol S, Stanchi F, Sudaka A, Brunstein MC, et al. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression. Acta Oncol 2008; 47:1502-12.
141. Hofman P, Butori C, Havet K, Hofman V, Selva E, Guevara N, et al. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. Br J Cancer 2008; 98:956-64. (Pubitemid 351341605)
142. Timpson P, Wilson AS, Lehrbach GM, Sutherland RL, Musgrove EA, Daly RJ. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. Cancer Res 2007; 67:9304-14. (Pubitemid 47535919)
143. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 2003; 78:323-35. (Pubitemid 36543212)
144. van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, et al. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (premalignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. BMC Cancer 2006; 6:58.
145. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M, et al. Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 2001; 61:6906-11. (Pubitemid 32896517)
146. Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, Tsuchiya A, et al. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 2004; 41:629-36. (Pubitemid 39297799)
147. Helwani FM, Kovacs EM, Paterson AD, Verma S, Ali RG, Fanning AS, et al. Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization. J Cell Biol 2004; 164:899-910. (Pubitemid 38366901)
148. Zhang K, Wang D, Song J. Cortactin is involved in transforming growth factor-beta1-induced epithelial-mesenchymal transition in AML-12 cells. Acta Biochim Biophys Sin (Shanghai) 2009; 41:839-45.
149. Blouw B, Seals DF, Pass I, Diaz B, Courtneidge SA. A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. Eur J Cell Biol 2008; 87:555-67.
150. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114:33-45. (Pubitemid 36859839)
151. Bertos NR, Gilquin B, Chan GK, Yen TJ, Khochbin S, Yang XJ. Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention. J Biol Chem 2004; 279:48246-54. (Pubitemid 39540981)
152. Huang R, Cao GJ, Guo H, Kordowska J, Albert Wang CL. Direct interaction between caldesmon and cortactin. Arch Biochem Biophys 2006; 456:175-82. (Pubitemid 44880287)
153. Chen X, Kojima S, Borisy GG, Green KJ. p120 catenin associates with kinesin and facilitates the transport of cadherin-catenin complexes to intercellular junctions. J Cell Biol 2003; 163:547-57. (Pubitemid 37429868)
154. Daniel JM, Reynolds AB. The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 1999; 19:3614-23. (Pubitemid 29193821)
155. Davis MA, Ireton RC, Reynolds AB. A core function for p120-catenin in cadherin turnover. J Cell Biol 2003; 163:525-34. (Pubitemid 37429866)
156. Stork B, Engelke M, Frey J, Horejsi V, Hamm-Baarke A, Schraven B, et al. Grb2 and the non-T cell activation linker NTAL constitute a Ca(2+)-regulating signal circuit in B lymphocytes. Immunity 2004; 21:681-91.
157. Di Fulvio M, Frondorf K, Henkels KM, Lehman N, Gomez-Cambronero J. The Grb2/PLD2 interaction is essential for lipase activity, intracellular localization and signaling in response to EGF. J Mol Biol 2007; 367:814-24. (Pubitemid 46330378)
158. Abella JV, Parachoniak CA, Sangwan V, Park M. Dorsal ruffle microdomains potentiate Met receptor tyrosine kinase signaling and downregulation. J Biol Chem 285:24956-67.
159. v1.2 modulates its interaction with the actin-binding protein cortactin. J Biol Chem 2002; 277:38596-606.
160. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 1992; 68:545-60.
161. Stuible M, Dube N, Tremblay ML. PTP1B regulates cortactin tyrosine phosphorylation by targeting Tyr446. J Biol Chem 2008; 283:15740-6.
162. Okamura H, Resh MD. p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells. J Biol Chem 1995; 270:26613-8. (Pubitemid 3006243)
163. Oser M, Dovas A, Cox D, Condeelis J. Nck1 and Grb2 localization patterns can distinguish invadopodia from podosomes. Eur J Cell Biol 2010; In press.
164. Oser M, Mader CC, Gil-Henn H, Magalhaes M, Bravo-Cordero JJ, Koleske AJ, et al. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J Cell Sci 123:3662-73.
165. Zhang X, Shrikhande U, Alicie BM, Zhou Q, Geahlen RL. Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells. Mol Cancer Res 2009; 7:634-44.
166. Linder S, Aepfelbacher M. Podosomes: adhesion hotspots of invasive cells. Trends Cell Biol 2003; 13:376-85. (Pubitemid 36776715)
167. Spinardi L, Rietdorf J, Nitsch L, Bono M, Tacchetti C, Way M, et al. A dynamic podosome-like structure of epithelial cells. Exp Cell Res 2004; 295:360-74. (Pubitemid 38490492)
168. Campbell DH, Sutherland RL, Daly RJ. Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res 1999; 59:5376-85. (Pubitemid 29504008)
169. Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E, et al. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 1998; 93:605-15. (Pubitemid 28240721)
170. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79:143-80. (Pubitemid 29056951)
171. Vidal C, Geny B, Melle J, Jandrot-Perrus M, Fontenay-Roupie M. Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading: implication of the cortical-actin binding protein cortactin. Blood 2002; 100:4462-9. (Pubitemid 35429686)
172. Stofega MR, Sanders LC, Gardiner EM, Bokoch GM. Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions. Mol Biol Cell 2004; 15:2965-77. (Pubitemid 38691883)
173. Lu W, Mayer BJ. Mechanism of activation of Pak1 kinase by membrane localization. Oncogene 1999; 18:797-806. (Pubitemid 29080338)
174. Shang X, Zhou YT, Low BC. Concerted regulation of cell dynamics by BNIP-2 and Cdc42GAP homology/ Sec14p-like, proline-rich and GTPase-activating protein domains of a novel Rho GTPase-activating protein, BPGAP1. J Biol Chem 2003; 278:45903-14. (Pubitemid 37432736)
175. Lua BL, Low BC. BPGAP1 interacts with cortactin and facilitates its translocation to cell periphery for enhanced cell migration. Mol Biol Cell 2004; 15:2873-83. (Pubitemid 38691875)
176. Le Clainche C, Pauly BS, Zhang CX, Engqvist-Goldstein AE, Cunningham K, Drubin DG. A Hip1R-cortactin complex negatively regulates actin assembly associated with endocytosis. EMBO J 2007; 26:1199-210. (Pubitemid 46398700)
177. Tian L, Chen L, McClafferty H, Sailer CA, Ruth P, Knaus HG, et al. A noncanonical SH3 domain binding motif links BK channels to the actin cytoskeleton via the SH3 adapter cortactin. FASEB J 2006; 20:2588-90.
178. Randazzo PA, Andrade J, Miura K, Brown MT, Long YQ, Stauffer S, et al. The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton. Proc Natl Acad Sci USA 2000; 97:4011-6. (Pubitemid 30226078)
179. Inoue H, Ha VL, Prekeris R, Randazzo PA. Arf GTPase-activating protein ASAP1 interacts with Rab11 effector FIP3 and regulates pericentrosomal localization of transferrin receptor-positive recycling endosome. Mol Biol Cell 2008; 19:4224-37.
180. Bharti S, Inoue H, Bharti K, Hirsch DS, Nie Z, Yoon HY, et al. Src-dependent phosphorylation of ASAP1 regulates podosomes. Mol Cell Biol 2007; 27:8271-83. (Pubitemid 350234239)
181. Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, Hirose M, et al. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol 2008; 10:85-92.
182. Taagepera S, McDonald D, Loeb JE, Whitaker LL, McElroy AK, Wang JY, et al. Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci USA 1998; 95:7457-62. (Pubitemid 28293274)
183. Zipfel PA, Zhang W, Quiroz M, Pendergast AM. Requirement for Abl kinases in T cell receptor signaling. Curr Biol 2004; 14:1222-31. (Pubitemid 38991808)
184. Matas OB, Martinez-Menarguez JA, Egea G. Association of Cdc42/N-WASP/Arp2/3 signaling pathway with Golgi membranes. Traffic 2004; 5:838-46. (Pubitemid 39433554)
185. Mizutani K, Miki H, He H, Maruta H, Takenawa T. Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. Cancer Res 2002; 62:669-74. (Pubitemid 34126939)
186. Henley JR, McNiven MA. Association of a dynamin-like protein with the Golgi apparatus in mammalian cells. J Cell Biol 1996; 133:761-75. (Pubitemid 26160979)
187. Jones SM, Howell KE, Henley JR, Cao H, McNiven MA. Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science 1998; 279:573-7. (Pubitemid 28067288)
188. Cao H, Garcia F, McNiven MA. Differential distribution of dynamin isoforms in mammalian cells. Mol Biol Cell 1998; 9:2595-609. (Pubitemid 28425896)
189. McNiven MA, Kim L, Krueger EW, Orth JD, Cao H, Wong TW. Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J Cell Biol 2000; 151:187-98.
190. Redecker P, Bockmann J, Bockers TM. Secretory granules of hypophyseal and pancreatic endocrine cells contain proteins of the neuronal postsynaptic density. Cell Tissue Res 2007; 328:49-55. (Pubitemid 46411906)
191. Sala C, Piech V, Wilson NR, Passafaro M, Liu G, Sheng M. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 2001; 31:115-30. (Pubitemid 32757093)
192. Du Y, Weed SA, Xiong WC, Marshall TD, Parsons JT. Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol 1998; 18:5838-51. (Pubitemid 28450535)
193. Boeckers TM. The postsynaptic density. Cell Tissue Res 2006; 326:409-22. (Pubitemid 44435817)
194. + exchanger 3. J Biol Chem 2006; 281:1461-9.
195. McWilliams RR, Gidey E, Fouassier L, Weed SA, Doctor RB. Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells. Biochem J 2004; 380:181-91. (Pubitemid 38725743)
196. Hou P, Estrada L, Kinley AW, Parsons JT, Vojtek AB, Gorski JL. Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape. Hum Mol Genet 2003; 12:1981-93. (Pubitemid 37038807)
197. Estrada L, Caron E, Gorski JL. Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane. Hum Mol Genet 2001; 10:485-95. (Pubitemid 32181671)
198. Le Bras S, Massaad M, Koduru S, Kumar L, Oyoshi MK, Hartwig J, et al. WIP is critical for T cell responsiveness to IL-2. Proc Natl Acad Sci USA 2009; 106:7519-24.
199. Martinez-Quiles N, Rohatgi R, Anton IM, Medina M, Saville SP, Miki H, et al. WIP regulates N-WASP-mediated actin polymerization and filopodium formation. Nat Cell Biol 2001; 3:484-91. (Pubitemid 32422084)
200. de la Fuente MA, Sasahara Y, Calamito M, Anton IM, Elkhal A, Gallego MD, et al. WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP). Proc Natl Acad Sci USA 2007; 104:926-31. (Pubitemid 46154713)
201. Brown M, Adyshev D, Bindokas V, Moitra J, Garcia JG, Dudek SM. Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium. Microvasc Res 80:75-88.
202. Dudek SM, Birukov KG, Zhan X, Garcia JG. Novel interaction of cortactin with endothelial cell myosin light chain kinase. Biochem Biophys Res Commun 2002; 298:511-9. (Pubitemid 35333688)
203. Lin J, Liu J, Wang Y, Zhu J, Zhou K, Smith N, et al. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene 2005; 24:2059-66. (Pubitemid 40516199)
204. Gonzalez-Quevedo R, Shoffer M, Horng L, Oro AE. Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/ BEG4. J Cell Biol 2005; 168:453-63. (Pubitemid 40205067)
205. Lynch DK, Winata SC, Lyons RJ, Hughes WE, Lehrbach GM, Wasinger V, et al. A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J Biol Chem 2003; 278:21805-13. (Pubitemid 36792585)
206. Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N, et al. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 1998; 94:667-77. (Pubitemid 28427585)
207. Brett TJ, Traub LM, Fremont DH. Accessory protein recruitment motifs in clathrin-mediated endocytosis. Structure 2002; 10:797-809. (Pubitemid 34628709)
208. Welsch T, Endlich N, Gokce G, Doroshenko E, Simpson JC, Kriz W, et al. Association of CD2AP with dynamic actin on vesicles in podocytes. Am J Physiol Renal Physiol 2005; 289:1134-43.
209. Monzo P, Mari M, Kaddai V, Gonzalez T, Le Marchand-Brustel Y, Cormont M. CD2AP, Rabip4 and Rabip4': analysis of interaction with Rab4a and regulation of endosomes morphology. Methods Enzymol 2005; 403:107-18.
210. Cormont M, Meton I, Mari M, Monzo P, Keslair F, Gaskin C, et al. CD2AP/CMS regulates endosome morphology and traffic to the degradative pathway through its interaction with Rab4 and c-Cbl. Traffic 2003; 4:97-112. (Pubitemid 36621703)